Innovation Pharmaceuticals Inc (IPIX)

[makarr]

Prurisol isn't being sold before results are provided; that is fairly obvious, and to suggest otherwise shows a lack of knowledge about how these markets work.

Anyway, clearly the success of CTIX as a company and stock comes down to the P2B prurisol result (and to a lesser extent B-OM). The Ph2A showed a chance of success in this trial at the higher dose, but due to the small sample sizes/non-compliance and some questionable management decisions (poor data dissemination, attacking a short seller on SeekingAlpha--you don't see a lot of other companies doing this), I personally feel likelihood of success is closer to a coin flip at this point.